Results 191 to 200 of about 33,363 (299)

Prevalence of White Coat Hypertension in Patients with Chronic Kidney Disease

open access: diamond, 2018
Rozita Mohd   +5 more
openalex   +2 more sources

Maternal and Perinatal Outcomes of White Coat Hypertension During Pregnancy

open access: green, 2020
Sonia Johnson   +4 more
openalex   +2 more sources

Human Cyclophilins—An Emerging Class of Drug Targets

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...
Katarina Jurkova   +3 more
wiley   +1 more source

Reply to Letter to the Editor: "HADS-A in White Coat Hypertension: Limitations and Future Directions". [PDF]

open access: yesAnatol J Cardiol
Güler Y   +8 more
europepmc   +1 more source

White coat hypertension: European versus American guidelines-A new dilemma. [PDF]

open access: yesJ Clin Hypertens (Greenwich), 2020
Cuspidi C, Paoletti F, Tadic M.
europepmc   +1 more source

Which Patients With Dysfunctional Voiding Respond Well to Sacral Neuromodulation? ICI‐RS 2025

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Aims Dysfunctional voiding (DV) is characterised by fluctuating or intermittent urinary flow during voiding in neurologically normal individuals. Given the different definitions used and heterogeneous pathophysiologies, outcomes following sacral neuromodulation/sacral nerve stimulation (SNM/SNS) are variably reported.
Jalesh N. Panicker   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy